A Randomized Phase 2 Study of the Combination of Pembrolizumab (MK-3475) PlusEpacadostat (INCB024360) with Platinum-based Chemotherapy Plus Placebo as First-Line Treatmentin Patients with Metastatic Non-Small Cell Lung Cancer (KN715/ECHO-306) (NCT03322566)
Project details
Funding institution
Diğer (Uluslararası)
Duration
16.01.2018 – 01.04.2019
Institution
0
Unit
Faculty of Medicine • Department of Internal Medicine
